Serological Assays for the Detection and Characterization of Influenza Viruses

Frist:22 May 2025, 14:00 GMT-4

Ausschreibungsinformationen

SAM.gov

ATLANTA, United States

Art: Solicitation
Verfahren: Solicitation
Referenznummer: dc73a610c43149ee82979ccc045cb9ff
NAICS: 325413

Amendment 3 is being issued to amend the timeline for Phase I. The new ship date for the assays is March 31, 2025 with a delivery date of April 1, 2025. The due date for results is April 15, 2025. Additional information …

will be provided in the packages to answer any lingering questions. The objective of this contract is to support the Influenza Division through the testing of human sera via hemagglutination inhibition assay as well as develop a new serology platform that is comparable to hemagglutination inhibition

assay. The steps in Phase I are as follows: Letter of Interest � offerors shall email POC information to Contracting Officer Proficiency panel will be sent by CDC to intersted offerors Vendor shall email results to CDC Contracting Officer

Alle Ausschreibungsinformationen anzeigen

Dokumente

Alle wichtigen Termine anzeigen